BioCentury
ARTICLE | Company News

PharmaMar sales and marketing update

May 9, 2016 7:00 AM UTC

The U.K.’s NICE issued final guidance recommending against the use of Yondelis trabectedin from PharmaMar to treat the first recurrence of platinum-sensitive ovarian cancer. The agency said that the ...